Citation tools
"Longterm Effect of Delaying Combination Therapy with Tumor Necrosis Factor Inhibitor in Patients with Aggressive Early Rheumatoid Arthritis: 10-year Efficacy and Safety of Adalimumab from the Randomized Controlled PREMIER Trial with Open-label Extension." The Journal of Rheumatology
(2013):
jrheum.130543.
Web. 23 April. 2024.